Vaxcyte (PCVX) Completes Enrollment for Phase 3 VAX-31 Clinical Trials

Stocks Yahoo Finance By Yahoo Finance 29 May 2026 06:40 1 min read

Vaxcyte (PCVX) Completes Enrollment for Phase 3 VAX-31 Clinical Trials

Vaxcyte (PCVX) Completes Enrollment for Phase 3 VAX-31 Clinical Trials

Vaxcyte (PCVX) Completes Enrollment for Phase 3 VAX-31 Clinical Trials

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.